Cargando…
Design, Synthesis and Biological Evaluation of Sulfamide and Triazole Benzodiazepines as Novel p53-MDM2 Inhibitors
A series of sulfamide and triazole benzodiazepines were obtained with the principle of bioisosterism. The p53-murine double minute 2 (MDM2) inhibitory activity and in vitro antitumor activity were evaluated. Most of the novel benzodiazepines exhibited moderate protein binding inhibitory activity. Pa...
Autores principales: | Yu, Zhiliang, Zhuang, Chunlin, Wu, Yuelin, Guo, Zizhao, Li, Jin, Dong, Guoqiang, Yao, Jianzhong, Sheng, Chunquan, Miao, Zhenyuan, Zhang, Wannian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200789/ https://www.ncbi.nlm.nih.gov/pubmed/25198897 http://dx.doi.org/10.3390/ijms150915741 |
Ejemplares similares
-
A novel drug discovery strategy: Mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways
por: Zhuang, Chunlin, et al.
Publicado: (2014) -
Synthesis of New Fused Benzothiadiazepines and Macrocyclic Sulfamides Starting from N,N-Disubstituted Sulfamides and N(Boc)-Sulfamides
por: Dehamchia, Mohamed, et al.
Publicado: (2012) -
Benzylsulfamide
por: Gelbrich, Thomas, et al.
Publicado: (2011) -
Nickel-Catalyzed Asymmetric Hydrogenation of Cyclic Sulfamidate Imines: Efficient Synthesis of Chiral Cyclic Sulfamidates
por: Liu, Yuanhua, et al.
Publicado: (2019) -
Correction: Environment-sensitive turn-on fluorescent probes for p53–MDM2 protein–protein interaction
por: Liu, Tingting, et al.
Publicado: (2017)